Letters: No reason to stop scrips for anticholinergics

GP reports a study by Singh (JAMA 2008; 300: 1,439-50) on anticholinergic inhalers and CVD risk (GP, 26 September).

The study found no causal link between anticholinergic inhalers and CVD, but an association. The justification for the study came from the finding of a previous meta-analysis reported by the FDA which found that tiotropium was associated with an increased risk of stroke.

No association was found with stroke in the new study by Singh et al but, instead, a different set of associations was reported.

In our view, the Singh study has several methodological problems including double counting patients, comparing tiotropium to both active treatments and placebos and failing to account for increased drop-outs in the placebo arms as this resulted in a smaller risk of adverse events.

The findings of an increased risk of cardiovascular events are interesting, and merit further consideration, but are not a reason to change prescribing. The results of the UPLIFT study to be released this month may clarify the safety profile of tiotropium.

We believe Dr Yoon's comments in your article are completely inappropriate. GPs should not change the way they prescribe anticholinergic inhalers on the basis of this single study unless advised by independent bodies. There is no clinical rationale to prescribe anticholinergics for short-term use - they are to treat symptoms and prevent exacerbations of a long-term progressive condition.

Long-term benefits of anticholinergic inhalers have been demonstrated and are reported in UK national and all international guidelines. Dr Yoon's recommendations to GPs on the basis of his single study will cause unnecessary distress to patients and confusion to clinicians.

GPs should allow time for the findings to be considered in the light of other scientific data and reach a calm objective conclusion before they change their prescribing habits.

Professor David Price, professor of primary care respiratory medicine, Aberdeen University; Dr Rupert Jones, GP in Plymouth; Dr Dermot Ryan, GP in Loughborough; Dr Mike Thomas, GP in Gloucestershire; Dr Daryl Freeman, GP in Norfolk; Dr John Haughney, GP in Scotland.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

Kamila Hawthorne

GP crisis could force one in four practices to close, says RCGP

Unmanageable pressure could force more than a quarter of GP practices to close, polling...

COVID-19 vaccine in pregnancy

Vaccination in pregnancy cuts COVID-19 risk for mother and baby

Vaccination against COVID-19 during pregnancy reduces the risk of infection and hospitalisation...

Child using smartphone

NICE backs digital CBT games for children with anxiety or low mood

GPs could prescribe CBT-based digital games, videos and quizzes for children and...

GP surgery sign

GP pressure to continue as experts warn NHS backlog will remain through 2023

General practice faces continuing heavy pressure after experts warned that the record...

Close-up of a man loading a shotgun

BMA updates GP firearms guidance as digital marker goes live on EMIS

The BMA has updated its guidance for GPs on firearms licensing following the release...

Map pins

Severely underdoctored areas spread across nearly every NHS region

Severely underdoctored areas exist in nearly every NHS region across England, figures...